Victorian State Minister for Industry and Employment Wade Noonan paid a visit to biopharmaceutical company CSL Behring in Broadmeadows on 24 August, for a tour of its manufacturing facility.

The tour took in CSL Behring’s state-of-the-art production line, where the company develops and manufactures a range of plasma protein biotherapies. It was accompanied by a detailed explanation of the processes used to make CSL Behring’s products, as well as the rigorous quality controls to which the company must adhere. Also in attendance was Frank McGuire MP, Local Member for Broadmeadows and Parliamentary Secretary for Medical Research.

CSL Behring is a global leader in therapies derived from human plasma. More than 700 employees work at the company’s purpose-built advanced manufacturing facility in Broadmeadows. CSL Behring manufactures 15 plasma products from blood donors in Australia and the Asia Pacific. The company’s products help treat and prevent a range of human medical conditions, and are exported worldwide.

In December 2015, a five-year construction and development project at Broadmeadows culminated with the first shipment of a state-of-the-art, highly engineered immunoglobulin product ‘Privigen’, exported to patients in the US. CSL Behring is a subsidiary of CSL Limited, an ASX top 10 company and the only advanced manufacturer in the ASX top 20.

In June, CSL Behring was named Large Manufacturer of the Year at the 2016 Manufacturing Hall of Fame Gala Dinner.